References
- Iseman M D. Mycobacterium avium complex and the normal host. The other side of the coin. N Engl Med J 1989; 321: 896–898
- Prince D S, Peterson D D, Steiner R M, Gottlieb J E, Scott R, Israel H L, Figueroa W G, Fish J E. Infection with Mycobacterium avium complex in patients without predisposing conditions. N Engl J Med 1989; 321: 863–868
- Wallace R J, O'Brien R, Glassroth J, Raleigh J, Dutt A. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am Rev Respir Dis 1990; 142: 940–953
- Hansen K N, Heltberg I, Hjelt K. Sensitivity to tuberculin and sensitins from atypical mycobacteria (M. chelonae subsp. abscessus, M. avium, M. intracellulare, M. scrofulaceum) in 100 Danish school children. Dan Med Bull 1989; 36: 399–401
- Engbæk H C, Vergman B, Bentzon M W. A prospective study of lung disease caused by Mycobacterium avium/Mycobacterium intracellulare. Eur J Respir Dis 1984; 65: 411–418
- Drake T A, Hindler J A, Berlin O GW, Brukner D A. Rapid identification of M. avium complex in culture using DNA probes. J Clin Microbiol 1987; 25: 1442–1445
- Wayne L G. The atypical mycobacteria: Recognition and disease association. Crit Rev Microbiol 1985; 12: 185–222
- Canetti G, Froman S, Grosset J, Hauduroy P, Langerova M, Mahler H T, Meissner G, Mitchison D A, Sula L. Mycobacteria: laboratory methods for testing drug sensitivity and resistance. Bull World Health Organ 1963; 29: 565–5678
- Siddiqi S H, Hawkins J E, Middlebrook G. Evaluation of a rapid radiometric method for drug susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol 1981; 13: 908–912
- Welch D F, Kelly M T. Antimicrobial susceptibility testing of Mycobacterium fortuitum complex. Antimicrob Agents Chemother 1979; 15: 754–757
- Polgar G, Promadhat V. Pulmonary function testing in children: techniques and standards. Saunders, Philadelphia 1971
- Quanjer Ph H. Standardized lung function testing. Report of working party on “Standardization of lung function tests”, European Community for Coal and Steel. Bull Eur Physiopathol Respir 1983; 19(suppl 5)1–95
- Andersen E, Hutchings B, Jansen J, Nyholm M. Heights and weights of Danish children. Ugeskr Læger 1982; 144: 1760–1765
- Del Beccaro M A, Mendelman P M, Nolan C. Diagnostic usefulness of mycobacterial skin test antigens in childhood lymphadenitis. Pediatr Infect Dis J 1989; 8: 206–210
- Hasløv K, Heron I. The generation of guinea pig T-cell lines reactive to antigens from Mycobacterium tuberculosis. Selected lines induce erythematous skin reactions. Scand J Immunol 1989; 29: 281–288
- Hjelte L, Petrini B, Källenius G, Strandvik B. Prospective study of mycobacterial infections in patients with cystic fibrosis. Thorax 1990; 45: 397–400
- Mulherin D, Coffey M J, Halloran D O, Keogan M T, FitzGerald M X. Skin reactivity to atypical mycobacteria in cystic fibrosis. Respir Med 1990; 84: 273–276
- Høiby N, Friis B, Jensen K, Koch C, Møller N E, Støvring S, Scaff M. Antimicrobial chemotherapy in cystic fibrosis patients. Acta Pædiatr Scand Suppl 1982; 301: 75–100
- Schiøtz P O. Systemic and mucosal immunity and nonspecific defense mechanisms in cystic fibrosis. Acta Pædiatr Scand Suppl 1982; 301: 55–62
- Banks J. Treatment of pulmonary disease caused by opportunistic mycobacteria. Thorax 1989; 44: 449–454
- Kinney J S, Little B J, Yolken R H, Rosenstein B J. Mycobacterium avium complex in a patient with cystic fibrosis. disease vs. colonization. Pediatr Infect Dis J 1989; 8: 393–396
- Boxerbaum B. Isolation of rapidly growing mycobacteria in patients with cystic fibrosis. J Pediatr 1980; 96: 689–691
- Smith M J, Efthimiou J, Hodson M E, Batten J C. Mycobacterial isolations in young adults with cystic fibrosis. Thorax 1984; 39: 369–375
- Wallace R J, Swenson J M, Silcox V A, Bullen M G. Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities. J Infect Dis 1985; 152: 500–514